Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin van den Bent; AA Brandes; MJB Taphoorn; J.M. Kros; Mathilde Kouwenhoven; JY Delattre; HJJA Bernsen; M Frenay; CC Tijssen; W Grisold; L Sipos; RH Enting; Pim French; Winand Dinjens; CJ Vecht; A Allgeier; D Lacombe; T Gorlia; K Hoang-Xuan

doi:10.1200/JCO.2012.43.2229

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin van den Bent, AA Brandes, MJB Taphoorn, J.M. Kros, Mathilde Kouwenhoven, JY Delattre, HJJA Bernsen, M Frenay, CC Tijssen, W Grisold, L Sipos, RH Enting, Pim French, Winand Dinjens, CJ Vecht, A Allgeier, D Lacombe, T Gorlia, K Hoang-Xuan

Research output: Contribution to journal › Article › Academic › peer-review

835 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	344-350
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	31
Issue number	3
DOIs	https://doi.org/10.1200/JCO.2012.43.2229
Publication status	Published - 2013

Access to Document

10.1200/JCO.2012.43.2229

http://hdl.handle.net/1765/68627

Cite this

van den Bent, M., Brandes, AA., Taphoorn, MJB., Kros, J. M., Kouwenhoven, M., Delattre, JY., Bernsen, HJJA., Frenay, M., Tijssen, CC., Grisold, W., Sipos, L., Enting, RH., French, P., Dinjens, W., Vecht, CJ., Allgeier, A., Lacombe, D., Gorlia, T., & Hoang-Xuan, K. (2013). Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951. Journal of Clinical Oncology, 31(3), 344-350. https://doi.org/10.1200/JCO.2012.43.2229

@article{930ca1954e2d4c76b70eb712f40c6dea,

title = "Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951",

author = "{van den Bent}, Martin and AA Brandes and MJB Taphoorn and J.M. Kros and Mathilde Kouwenhoven and JY Delattre and HJJA Bernsen and M Frenay and CC Tijssen and W Grisold and L Sipos and RH Enting and Pim French and Winand Dinjens and CJ Vecht and A Allgeier and D Lacombe and T Gorlia and K Hoang-Xuan",

year = "2013",

doi = "10.1200/JCO.2012.43.2229",

language = "Undefined/Unknown",

volume = "31",

pages = "344--350",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "3",

}

van den Bent, M, Brandes, AA, Taphoorn, MJB, Kros, JM, Kouwenhoven, M, Delattre, JY, Bernsen, HJJA, Frenay, M, Tijssen, CC, Grisold, W, Sipos, L, Enting, RH, French, P , Dinjens, W, Vecht, CJ, Allgeier, A, Lacombe, D, Gorlia, T & Hoang-Xuan, K 2013, 'Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951', Journal of Clinical Oncology, vol. 31, no. 3, pp. 344-350. https://doi.org/10.1200/JCO.2012.43.2229

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951. / van den Bent, Martin; Brandes, AA; Taphoorn, MJB et al.

In: Journal of Clinical Oncology, Vol. 31, No. 3, 2013, p. 344-350.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

AU - van den Bent, Martin

AU - Brandes, AA

AU - Taphoorn, MJB

AU - Kros, J.M.

AU - Kouwenhoven, Mathilde

AU - Delattre, JY

AU - Bernsen, HJJA

AU - Frenay, M

AU - Tijssen, CC

AU - Grisold, W

AU - Sipos, L

AU - Enting, RH

AU - French, Pim

AU - Dinjens, Winand

AU - Vecht, CJ

AU - Allgeier, A

AU - Lacombe, D

AU - Gorlia, T

AU - Hoang-Xuan, K

PY - 2013

Y1 - 2013

U2 - 10.1200/JCO.2012.43.2229

DO - 10.1200/JCO.2012.43.2229

M3 - Article

VL - 31

SP - 344

EP - 350

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 3

ER -